Søgning på udtrykket 'covid-19' giver 79 resultater
Dokumenter [7]
Sider [2]
Kalender [29]
Nyt fra tidsskrifterne [+20]
Aktuelle smitsomme sygdomme [+20]
Dokumenter [7]
Dette notat omfatter patienter med følger efter infektion med SARS-CoV-2. Aktuelt defineres vedvarende symptomer ≥4 uger efter infektionsstart som langvarige symptomer, og vedvarende symptomer ≥12 uger anses som senfølger efter COVID-19.
Denne vejledning er tiltænkt diagnostik og behandling af COVID-19. Denne retningslinje vil løbende blive opdateret, som ny evidens kommer frem. Der er ikke foretaget en gradering af evidensniveau.
Ændringer i denne udgave:
Remdesivir står ikke længere som relativt kontraindiceret ved påvirket nyrefunktion.
Invitation til møde den 20. maj 2022
COVID-19 pandemien: Erfaringer vedrørende migranter og etniske
minoriteters sundhed
DSI anbefaler fortsat remdesivir ved indlæggelsekrævende COVID-19 med behov for tilskud af ilt, hvor iltmætningen i blodet er under 94% uden ilttilskud hos ellers lungeraske og, at hvor der ved røntgen af thorax påvises infiltrat(er).
Dette holdningspapir omhandler baggrunden for anbefalingen.
Indlæg af formand Rikke Krogh-Madsen i Altinget om opgradering af det infektionsmedicinske speciale
Vurdering af behov for antivirale midler og effekt af SARS-CoV2 infektion i de risikogrupper, som ifølge gældende retningslinjer skal tilbydes behandling med lægemidlet.
Sider [2]
Borrelia:
Anne-Mette Lebech (tovholder), Christian Brandt, Fredrikke Christie Knudtzen, Helene Mens, Jacob Bodilsen, Sigurdur Skarphédinsson
Borrelia klaringsrapport (2014),
Diagnostik og behandling af Lyme neuroborreliose (2021),
COVID-19:
Michael Dalager-Pedersen (tovholder), Marie Helleberg, Gitte Kronborg, Isik Somuncu, Merete Storgaard, Lothar Wiese
COVID-19 retningslinje (2023v26),
Cystisk fibrose (SST's arbejdsgruppe til eftersyn af området vedrørende cyst
Professor Henrik Nielsen kommenterer: Så kom den endelig. Længe ventet, med spænding imødeset. Fagfællebedømt artikel om BioNTech/Pfizers BNT162b2 mRNA vaccine mod COVID-19. Selvfølgelig i NEJM og naturligvis af stor aktuel interesse, men vil også blive stående som en klassiker i medicinsk litteratur. En milepæl i vaccinologiens historie, blandt andet fordi der er anvendt en ny teknologisk platform og fordi studiet er kommet i mål på rekordtid. Alle infektionsmedicinere bør kende denne publikat
Kalender [29]
14. december 2022, Online
20. maj 2022, Aarhus Universitet
21. marts 2022, Aarhus Universitetshospital, Skejby
23. september 2021, Aarhus
21. september 2021, Online
31. august 2021, Holst Auditoriet, Mærsk Tårnet, København
30. december 2020, Online
9. oktober 2020, Århus og online
25. september 2020, Online
18. juni 2020, Aflyst på grund af COVID-19
3. juni 2020, Mødet udskudt på grund af COVID-19
24. marts 2020, København
Nyt fra tidsskrifterne [+20]
Der er mere end 20 resultater, måske du vil se
flere resultater her?
PLoS One Infectious Diseases
26.09.2023
Rusmawatiningtyas, Arie Z. Fatoni, Jose M. Mandei, Eka Y. Lantang, Fajar Perdhana, Bambang P. Semedi, Muhammad Rayhan, Tiffany R. S. Tarigan, Nicole White, Gianluigi L. Bassi, Jacky Y. Suen, John F. Fraser . Background Indonesia’s national response to COVID-19 evolved rapidly throughout 2020. Understanding pandemic response and outcomes is crucial for better mitigation strategies ahead. This study describes the characteristics and outcomes of patients admitted to ICU during the early stages of the pande
Journal of Acquired Immune Deficiency Syndromes
24.09.2023
Background: . The Covid-19 pandemic has created substantial and profound barriers to several forms of healthcare engagement. For Black sexual minority men, this may include engagement with pre-exposure prophylaxis (PrEP) to prevent HIV infection, with significant implications for HIV disparities. Our study explored how the Covid-19 pandemic affected Black sexual minority men, with a focus on relationships between Covid-19 and PrEP engagement. Setting: . We sampled 24 Black sexual minority men attending HI
Science Advances
23.09.2023
Science Advances, Volume 9, Issue 38, September 2023.
BMJ Open
22.09.2023
. Objective. COVID-19 would kill fewer people if health programmes can predict who is at higher risk of mortality because resources can be targeted to protect those people from infection. We predict mortality in a very large population in Mexico with machine learning using demographic variables and pre-existing conditions. . Design. Cohort study. . Setting. March 2020 to November 2021 in Mexico, nationally represented. . Participants. 1.4 million laboratory-confirmed patients with COVID-19 in Mexico at o
BMC Infectious Diseases
22.09.2023
. Abstract. . Background. Coronavirus disease 2019 (COVID-19) is a rapidly developing and sometimes lethal pulmonary disease. Accurately predicting COVID-19 mortality will facilitate optimal patient treatment and medical resource deployment, but the clinical practice still needs to address it. Both complete blood counts and cytokine levels were observed to be modified by COVID-19 infection. This study aimed to use inexpensiv
PLoS One Infectious Diseases
22.09.2023
s Celino, Nailton José Brandão de Albuquerque Filho, Monalisa da Nóbrega Cesarino Gomes, Gabriela Maria Cavalcanti Costa, Ana Elza Oliveira de Mendonça . Objective To evaluate the primary health care (PHC) attributes and associated factors during the COVID-19 pandemic using the perspective of users. Methods This cross-sectional, quantitative study included 422 PHC users from 96 Family Health Teams in a city in Brazil. The assessment used the Primary Care Assessment Tool (PCATool) and a structured ques
PLoS One Infectious Diseases
22.09.2023
by Jeremy Bingham, Stefano Tempia, Harry Moultrie, Cecile Viboud, Waasila Jassat, Cheryl Cohen, Juliet R.C. Pulliam . Objectives The aim of this study was to quantify transmission trends in South Africa during the first four waves of the COVID-19 pandemic using estimates of the time-varying reproduction number (R) and to compare the robustness of R estimates based on three different data sources, and using data from public and private sector service providers. Methods R was estimated from March 2020 throu
International Journal of Infectious Diseases
22.09.2023
We have read with great interest the article by Velavan et al. [1]. In this study, the authors showed how several soft and alcoholic drinks could be used to create false positive results with COVID-19 rapid antigen test (RAT) when using the Abott Panbio COVID-19 Ag Lateral Flow Test Cassette. RAT were massively introduced in 2021 as a point-of-care diagnosis tool. With a good specificity and sensitivity for several brands in the market [2], the speed and convenience of RAT made them available for self-testi
BMJ Open
22.09.2023
. Objectives. There is limited in-depth research exploring persistent symptoms and conditions among children and adolescents who contracted COVID-19 illness that required hospitalisation. The main objective of this study was to conduct qualitative interviews among families who had a child hospitalised with COVID-19 illness to elucidate their child’s physical, mental and social health outcomes months after initial acute infection. . Design, setting and participants. A qualitative study that composed of in
BMJ Open
22.09.2023
. Objectives. Despite growing evidence suggesting increased COVID-19 mortality among people from ethnic minorities, little is known about milder forms of SARS-CoV-2 infection. We sought to explore the association between ethnic background and the probability of testing, testing positive, hospitalisation, COVID-19 mortality and vaccination uptake. . Design. A multistate cohort analysis. Participants were followed between 8 April 2020 and 30 September 2021. . Setting. The UK Biobank, which stores medical da
BMC Infectious Diseases
22.09.2023
. Abstract. . Background. COVID-19 is a global pandemic. Understanding the immune responses in pregnant women recovering from COVID-19 may suggest new therapeutic approaches. . . . Methods. We performed a cross-sectional study between March 1, 2020, and September 1, 2020. Participants were assigned into the convalescent COVID-19 group if the
PLoS One Infectious Diseases
21.09.2023
the original blood test datasets. Seven machine learning tools Support Vector Machine, Extra Tree, Random Forest, Gradient Boosting Decision Tree, eXtreme Gradient Boosting, Logistic Regression, and ensemble learning were then used to diagnose and predict COVID-19. In addition, we used SHAP and scikit-learn post-hoc interpretability to report feature importance, allowing healthcare professionals and artificial intelligence models to interact to suggest biomarkers that some doctors may have missed. The 10-fo
PLoS One Infectious Diseases
21.09.2023
by Daniel T. L. Shek, Tingyin Wong, Xiang Li, Lu Yu . The use of online teaching mode has grown rapidly in recent years, particularly under the COVID-19 pandemic. To promote the learning motivation of students and teaching effectiveness, development of attractive online teaching material such as videos is important. In the present study, we developed 15 theory-related videos and 9 case-based videos in the context of a leadership course focusing on psychological well-being and psychosocial competence. Using
International Journal of Infectious Diseases
21.09.2023
Since the early phase of SARS-CoV-2 pandemic it has been questioned which groups of subjects were at higher risk of worse COVID-19 outcomes. This would have allowed firstly to implement specific preventing interventions, allocate therapeutic resources, and in the later phases of the pandemic prioritize COVID-19 vaccination. Demographic factors shortly appeared to be the main determinants of COVID-19 outcomes, with older age, male sex and social deprivation as strongly associated with hospitalization and dea
New England Journal of Medicine
21.09.2023
New England Journal of Medicine, Volume 389, Issue 12, Page 1085-1095, September 2023.
BMJ Open
21.09.2023
. Introduction. The implementation of COVID-19 pandemic-related restrictions resulted in limitations for physical activity (PA) opportunities, which may have initiated a longer-term behavioural change. The protocol describes the methodology for a planned systematic review that aims to summarise changes in PA and physical fitness (PF) in children and adolescents in the WHO European Region after the onset of the COVID-19 pandemic. . Methods and analysis. The protocol adheres to the ‘Preferred Reporting Ite
BMJ Open
21.09.2023
. Objectives. The COVID-19 pandemic affected provision and use of maternal health services. This study describes changes in obstetric complications, referrals, stillbirths and maternal deaths during the first year of the pandemic and elucidates pathways to these changes. . Design. Prospective observational mixed-methods study, combining monthly routine data (March 2019–February 2021) and qualitative data from prospective semi-structured interviews. Data were analysed separately, triangulated during synth
BMJ Open
21.09.2023
. Objective. To identify, review and synthesise qualitative literature on healthcare professionals’ adaptations to changes and challenges resulting from the COVID-19 pandemic. . Design. Systematic review with meta-synthesis. . Data sources. Academic Search Elite, CINAHL, MEDLINE, PubMed, Science Direct and Scopus. . Eligibility criteria. Qualitative or mixed-methods studies published between 2019 and 2021 investigating healthcare professionals’ adaptations to changes and challenges resulting f
BMC Infectious Diseases
21.09.2023
influencing factors for deterioration and length of stay (LOS) in hospitals among these non-severe cases. . . . Methods. This study included 12,555 non-severe cases with COVID-19 in largest shelter hospital of Shanghai, aiming to explore prognostic factors and build effective models for prediction of LOS. . . . Results. Data showed that 75
Aktuelle smitsomme sygdomme [+20]
Der er mere end 20 resultater, måske du vil se
flere resultater her?
Statens Serum Institut
25.09.2023
Der var ikke flere voksne, der blev indlagt med alvorlige infektionssygdomme, efter de havde været smittet med covid-19. Det viser en ny stor undersøgelse fra Statens Serum Institut, hvor 78.000 indlæggelser er blevet analyseret.
Medscape Infectious Diseases
23.09.2023
A real-world study found that Pfizer's COVID-19 antiviral Paxlovid is now less effective at preventing hospitalization or death in high-risk patients as compared with earlier studies. . WebMD Health News
Eurosurveillance latest updates
22.09.2023
. Background. The sensitivity and specificity of selected antigen detection rapid diagnostic tests (AG-RDTs) for SARS-CoV-2 were determined in the unvaccinated population when the Delta variant was circulating. Viral loads, dynamics, symptoms and tissue tropism differ between Omicron and Delta. . . Aim. We aimed to compare AG-RDT sensitivity and specificity in selected subgroups during Omicron vs Delta circulation. . . Methods. We retrospectively paired AG-RDT results with PCRs registered in Czechia’s
Eurosurveillance latest updates
15.09.2023
. Background. COVID-19 pandemic mitigation measures, including travel restrictions, limited global circulation of influenza viruses. In Australia, travel bans for non-residents and quarantine requirements for returned travellers were eased in November 2021, providing pathways for influenza viruses to be re-introduced. . . Aim. We aimed to describe the epidemiological and virological characteristics of the re-emergence of influenza in Victoria, Australia to inform public health interventions. . . Methods
Medscape Infectious Diseases
14.09.2023
However, an important take-home message from this new meta-analysis is that these widely used medications appeared to be safe even in acutely ill hospitalized patients, the researchers say. . Medscape Medical News
Medscape Infectious Diseases
12.09.2023
The FDA today authorized the newest COVID-19 vaccine, the first not to target the initial or 'ancestral' strain of the virus. . WebMD Health News
ECDC Epidemiological Update
8.09.2023
In recent weeks, signals of SARS-CoV-2 transmission have increased from previously very low levels in the EU/EEA.
ECDC COVID-19 updates
7.09.2023
In recent weeks, signals of SARS-CoV-2 transmission have increased from previously very low levels in the EU/EEA.
ECDC COVID-19 updates
7.09.2023
Today ECDC is providing an update on the current status of COVID-19 transmission in the European Union and European Economic Area (EU/EEA), the emergence of new SARS-CoV-2 variants, and public health considerations for Autumn 2023.
Medscape Infectious Diseases
1.09.2023
Last week COVID-19 hospitalizations rose by 19% and deaths rose by 21%, according to figures from the CDC. . WebMD Health News
Eurosurveillance latest updates
1.09.2023
. Background. We anticipated that people in rural areas and small towns with lower population density, lower connectivity and jobs less dependent on social interaction will be less exposed to COVID-19. Still, other variables correlated with socioeconomic inequalities may have a greater impact on transmission. . . Aim. We investigated how COVID-19 affected rural and urban communities in Poland, focussing on the most exposed groups and disparities in SARS-CoV-2 transmission. . . Methods. A random digit di
Medscape Infectious Diseases
25.08.2023
Primary care clinicians were sidelined in vaccine distribution during the height of the COVID-19 pandemic. But now these providers are looking toward resuming their role as a major provider of the shots. . Medscape Medical News
ECDC COVID-19 updates
23.08.2023
This document provides an update on the safety of substances of human origin (SoHO) in relation to COVID-19. It reassesses the risk and proposes revised mitigation measures for preventing transmission through SoHO.
Eurosurveillance latest updates
18.08.2023
. Background. The surveillance of persons hospitalised with COVID-19 has been essential to ensure timely and appropriate public health response. Ideally, surveillance systems should distinguish persons hospitalised with COVID-19 from those hospitalised due to COVID-19. . . Aim. We compared data in two national electronic health registries in Norway to critically appraise and inform the further development of the surveillance of persons hospitalised with COVID-19. . . Method. We included hospitalised COV
Morbidity and Mortality Weekly Report (MMWR)
18.08.2023
This report describes the effectiveness of monovalent and bivalent mRNA COVID-19 vaccines among children 6 months-5 yearsThis report describes the effectiveness of monovalent and bivalent mRNA COVID-19 vaccines among children 6 months-5 years
Eurosurveillance latest updates
11.08.2023
The COVID-19 pandemic highlighted some potential limitations of transmission-based precautions. The distinction between transmission through large droplets vs aerosols, which have been fundamental concepts guiding infection control measures, has been questioned, leading to considerable variation in expert recommendations on transmission-based precautions for COVID-19. Furthermore, the application of elements of contact precautions, such as the use of gloves and gowns, is based on low-quality and inconclusiv
Eurosurveillance latest updates
11.08.2023
April–June 2023), we found that a second or third booster of Comirnaty bivalent Original/Omicron BA.4-5 mRNA vaccine, versus a first booster received at least 120 days earlier, was effective in preventing severe COVID-19 for more than 6 months post-administration in persons 60 years and above. In view of autumn 2023 vaccination campaigns, use of bivalent Original/Omicron BA.4-5 mRNA vaccines might be warranted until monovalent COVID-19 vaccines targeting Omicron XBB.1 sublineages become available.
Morbidity and Mortality Weekly Report (MMWR)
11.08.2023
This report describes a study of COVID-like symptoms among adults up to 12 months after a positive or negative SARS-CoV-2 test.
ECDC COVID-19 updates
9.08.2023
The new joint report by ECDC and Eurofound concludes that adult work-life balance was significantly affected by measures such as stay-at-home orders and recommendations.
ECDC COVID-19 updates
9.08.2023
This report summarises results from an analysis conducted by ECDC and Eurofound to understand the impact of selected NPIs introduced from 2020 to 2022 in response to the COVID-19 pandemic on the WLB among EU adults.